 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| MJTV Executes on Merger and Sets Sight on Massive Market |
|
 Hot Stock to Watch
|
Company: Michael James Enterprises Inc. (Pink Sheets: MJTV)
|
End of Day:
Price: 0.55
Change (%): - 0.27 (32.93)
Volume: 16,766 |
 |
Michael James Enterprises of Delaware (Formerly BNBI) Signs Definitive Merger Agreement With Michael James Enterprises of Nevada
SHORT HILLS, NJ-(Marketwired - Dec 16, 2015) - Michael James Enterprises, Inc. (OTC PINK: MJTV), formerly known as Bullsnbears.com, Inc., a Delaware corporation, today announced that it has entered into a definitive agreement to merge with Michael James Enterprises, Inc., a Nevada corporation. The merger will be completed as soon as all regulatory filings have been submitted and accepted.
Michael James Enterprises, Inc., a New Jersey based company (MJE), has developed the most promising approach to treating acne since the introduction of Benzoyl Peroxide decades ago. A very high and unacceptable level of people are unable to use acne treatment products formulated with benzoyl peroxide due to its harmful effects to the skin while many other individuals look past these damaging effects in order to treat their acne. MJTV’s merger partner utilizes patented science from a world-renowned Ivy League institution to eliminate the need for Benzoyl Peroxide. MJE makes the claim that its offering not only treats acne as well as, if not better than, any other acne treatment system without the harmful side effects, but actually will improve an acne users skin complexion.
Continue Reading
|
 Yesterday's Top Performer
|
Company: APPYEA Inc. (OTCQB: APYP)
|
End of Day:
Price: 0.0033
Change (%): + 0.0003 (10.00)
Volume: 932,300 |
 |
About AppYea, Inc
AppYea Inc., founded in 2012, is a mobile application developer for iOS, Google Play, and Amazon platforms. The Company operates its own titles as well as provides strategic partnerships with promising mobile app developers. AppYea focuses on a number of different categories including next-generation social networks and gaming. The company is headquartered in Ft Worth, Texas. The Company trades under the symbol "APYP." Find out more by visiting: http://appyea.com/about/
To learn more about the APYP business model, history, business focus and future plans, listen to our recent interviews at SmallCapVoice.com here http://www.smallcapvoice.com/apyp/. |
Other Small Cap News
|
Company: MassRoots, Inc. (OTCQB: MSRT)
|
MassRoots Generates 35 Million App Screen Views in 30 Days, Releases New Corporate Overview Deck
DENVER, Dec. 16, 2015 (GLOBE NEWSWIRE) -- MassRoots, Inc. (OTCQB:MSRT), one of the largest and fastest growing social networks for cannabis consumers, is pleased to announce that from November 14 to December 13, 2015, MassRoots generated 35.3 million app screen views, defined as a user loading a new page within the MassRoots application. App screen views includes user activities like searching for users, hashtags and dispensaries, as well as viewing notifications and profiles. It does not include refreshing or loading additional posts in a user’s newsfeed.
MassRoots also released a new corporate overview deck, accessible online here and on the presentations page of MassRoots’ corporate site.
Continue Reading
|
Company: Regen BioPharma, Inc., (OTCBB: RGBP)
|
Regen BioPharma, Inc. Identifies Small Molecule Drug Candidates Targeting Its Proprietary Immune Checkpoint NR2F6
Company Augments Intellectual Property Portfolio by Filing Broad Patent Claims Covering New Biochemical Validation Data
SAN DIEGO, California, December 16, 2015 /PRNewswire/ -- Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today identification of a series of compounds that have been identified by biochemical testing which interact with the Company's newly identified immune checkpoint NR2F6. This is the first of a series of steps in developing small molecules which the Company plans to use as a basis for creating "a checkpoint inhibitor pill." Previously, the Company reported that the use of gene silencing of NR2F6 leads to induction of cancer stem cell differentiation, a process that renders malignant cancer cells benign.
"We are optimistic that these initial positive data will lead the way forward into what we hope will be a new generation of immune stimulatory cancer drugs: Orally-available agents that will on the one hand unleash anticancer immune responses and on the other hand directly reprogram cancers rendering them less malignant," said Harry Lander, Ph.D., President and Chief Scientific Officer of Regen.
Continue Reading
|
Company: Net Medical Xpress Solutions, Inc. (OTCQB: NMXS)
|
Net Medical Xpress Launches Telemedicine Building Blocks Technology for Neurology and Neurosurgery
Program Eliminates Time Consuming Phone Orders for Emergency Services
ALBUQUERQUE, NM--(Marketwired - Dec 16, 2015) - Net Medical Xpress Solutions, Inc. (OTCQB: NMXS), a provider of a wide range of telemedicine products and services, announced today the launch of its digital paper Telemed Building Blocks technology for Neurology and Neurosurgery.
Net Medical Xpress has implemented a quality improvement initiative called digital paper. This is a new process that uses a secure custom link on a hospital desktop to request a Neurology or Neurosurgery consultation. The link can be added to any smartphone, tablet or desktop. When a specialist consultation is required, a form is filled out electronically and instantly submitted to Net Medical's call center. Once the call center receives the request, a consult is expedited by simultaneously alerting members of the telemedicine team as well as the appropriate provider on duty.
Continue Reading
|
Company: Heritage Global Partners (OTCQB: HGBL)
|
Heritage Global Partners to Manage Global Online Auction of Industrial Robots and High-Technology Assets of EC Manufacturing Beginning January 19
Sale of Over 350 Lots Features Wide Array of Robots, Cameras, Lasers, Model Shop Machine Tools, Facility Equipment and More
SHAWNEE, Kan. & SAN DIEGO--(BUSINESS WIRE)--Heritage Global Partners (“HGP”), a worldwide leader in asset advisory and auction services and a subsidiary of Heritage Global Inc. (OTCQB: HGBL, CSE: HGP), today announced it will manage an upcoming global online auction featuring the late model high-tech manufacturing and equipment of EC Manufacturing (“ECM”) beginning January 19, 2016.
The sale includes high-quality assets used by ECM for contract work it completed on behalf of a Fortune 300 consumer packaged goods company.
Continue Reading |
Market News
|
By Alex Rosenberg | Stephanie Yang: CNBC
|
Marc Faber: This is ‘precisely the wrong time’ for Fed to hike
The Fed is set to raise rates at exactly the wrong time. So contends Marc Faber, the editor of the Gloom, Boom & Doom Report.
The long-bearish market watcher sometimes known as "Dr. Doom" says that, contrary to impressions, the economy in the U.S. and across the globe is slowly improving, "the global economy has decelerated very badly, and many countries are already in recession, or going into recession."
It is in the midst of this apparently tough environment that the Federal Reserve will present its rate decision on Wednesday afternoon. The central bank is widely expected to raise its benchmark target rate by 0.25 percent.
Continue Reading
|
By Matthew J. Belvedere: CNBC
|
Why the Fed has no choice on rates: Jack Welch
The Federal Reserve has to raise interest rates Wednesday for the first time in 9½ years because policymakers have painted themselves into a corner by not moving at the September meeting, said Jack Welch, management expert and former General Electric chief.
"It would have been better to go last time actually. Conditions were better," he told CNBC's "Squawk Box," referring to the widely expected hike that never materialized three months ago. "The economy is not any stronger. The commodities have gone further down."
The Fed also met in October, but few analysts had expected a rate hike then.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
